Agilent Technologies Inc（A）財務資料AAgilent Technologies Inc

Agilent Technologies Inc (A) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Non-instrumentation and other, accounting for 63.4% of total sales, equivalent to $1.14B. Another important revenue stream is Instrumentation. Understanding this composition is critical for investors evaluating how A navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Agilent Technologies Inc maintains a gross margin of 55.54%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 24.44%, while the net margin is 19.28%. These profitability ratios, combined with a Return on Equity (ROE) of 20.97%, provide a clear picture of how effectively A converts its operational activities into shareholder value.

In the context of the broader market, A competes directly with industry leaders such as EW and MDLN. With a market capitalization of $48.73B, it holds a significant position in the sector. When comparing efficiency, A's gross margin of 55.54% stands against EW's 77.46% and MDLN's 26.52%. Such benchmarking helps identify whether Agilent Technologies Inc is trading at a premium or discount relative to its financial performance.

Agilent has shown consistent revenue growth, with Q3 2026 revenue at $1.88 billion, an 8.1% year-over-year increase. The gross margin has improved to 55.54%, indicating strong operational efficiency. Net income for Q3 2026 was $362 million, reflecting solid profitability.